592 results on '"Jack Jr, Clifford"'
Search Results
2. A clinical perspective on the revised criteria for diagnosis and staging of Alzheimer’s disease
3. A multimodal clinical diagnostic approach using MRI and 18F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low–intermediate Alzheimer’s disease neuropathologic changes and primary age-related tauopathy
4. The clinical importance of suspected non-Alzheimer disease pathophysiology
5. Atypical Alzheimer’s disease: new insights into an overlapping spectrum between the language and visual variants
6. CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
7. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer’s disease pathology in the population?
8. Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies
9. Biomarker-based staging of Alzheimer disease: rationale and clinical applications
10. Cortical microstructural associations with CSF amyloid and pTau
11. Plasma biomarkers for prediction of Alzheimer’s disease neuropathologic change
12. Author Correction: Performance of plasma phosphorylated tau 181 and 217 in the community
13. Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI
14. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
15. Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer’s disease: a series of clinical cases
16. Differential effect of dementia etiology on cortical stiffness as assessed by MR elastography
17. Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
18. Performance of plasma phosphorylated tau 181 and 217 in the community
19. Deep learning-based brain age prediction in normal aging and dementia
20. Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer’s disease
21. A Bayesian Approach to Multi-State Hidden Markov Models: Application to Dementia Progression
22. Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging
23. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
24. Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels
25. Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration.
26. Cross-Sectional Associations of Peripheral Hearing, Brain Imaging, and Cognitive Performance With Speech-in-Noise Performance: The Aging and Cognitive Health Evaluation in Elders Brain Magnetic Resonance Imaging Ancillary Study.
27. Mayo Normative Studies: Amyloid and Neurodegeneration Negative Normative Data for the Auditory Verbal Learning Test and Sex-Specific Sensitivity to Mild Cognitive Impairment/Dementia.
28. Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure.
29. Patterns of Early Neocortical Amyloid-b Accumulation: A PET Population-Based Study.
30. Causal structure discovery identifies risk factors and early brain markers related to evolution of white matter hyperintensities
31. Imaging-based indices of Neuropathology and gait speed decline in older adults: the atherosclerosis risk in communities study
32. Diffusion tensor imaging analysis in three progressive supranuclear palsy variants
33. Developing the ATX(N) classification for use across the Alzheimer disease continuum
34. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
35. Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age–related tauopathy and Alzheimer's disease.
36. A multimodal clinical diagnostic approach using MRI and 18F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low–intermediate Alzheimer's disease neuropathologic changes and primary age-related tauopathy.
37. Patterns of Early Neocortical Amyloid-β Accumulation: A PET Population-Based Study.
38. Mayo normative studies: regression-based normative data for ages 30–91 years with a focus on the Boston Naming Test, Trail Making Test and Category Fluency.
39. Complex Relationships of Socieconomic Status with Vascular and Alzheimer's Pathways on Cognition
40. Modeling the temporal evolution of plasma p‐tau in relation to amyloid beta and tau PET
41. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
42. A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech
43. Genetic architecture of subcortical brain structures in 38,851 individuals
44. Prediction of Surgical Outcomes in Normal Pressure Hydrocephalus by MR Elastography.
45. Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity.
46. Modeling the temporal evolution of plasma p‐tau in relation to amyloid beta and tau PET.
47. Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes.
48. Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test.
49. Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s Disease
50. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.